Comprehensive analysis of West Nile virus-specific T cell responses in humans

Journal of Infectious Diseases

Volumn 197, Issue 9, 2008, Pages 1296-1306

  Lanteri, Marion C ^a   Heitman, John W ^a   Owen, Rachel E ^a,b   Busch, Thomas ^a   Gefter, Nelly ^a   Kiely, Nancy ^c   Kamel, Hany T ^c   Tobler, Leslie H ^a   Busch, Michael P ^a,b   Norris, Philip J ^a,b,d  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c Blood Systems Incorporated   (United States)

^d BLOOD SYSTEMS RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; GRANZYME B; NONSTRUCTURAL PROTEIN 3; NONSTRUCTURAL PROTEIN 4B; PEPTIDE DERIVATIVE; PERFORIN;

ADULT; AGED; ARTICLE; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN CELL; MALE; NONHUMAN; NUCLEOTIDE SEQUENCE; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; T LYMPHOCYTE; VIRUS GENOME; WEST NILE FLAVIVIRUS;

CD8-POSITIVE T-LYMPHOCYTES; HUMANS; LEUKOCYTES, MONONUCLEAR; PEPTIDES; T-LYMPHOCYTES; WEST NILE FEVER; WEST NILE VIRUS;

EID: 43049114537     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/586898     Document Type: Article

References (51)

1. Hayes EB, Sejvar JJ, Zaki SR, Lanciotti RS, Bode AV, Campbell GL. Virology, pathology, and clinical manifestations of West Nile virus disease. Emerg Infect Dis 2005; 11:1174-9.
2. Mukhopadhyay S, Kim BS, Chipman PR, Rossmann MG, Kuhn RJ. Structure of West Nile virus. Science 2003; 302:248.
3. Mostashari F, Bunning ML, Kitsutani PT, et al. Epidemic West Nile encephalitis, New York, 1999: results of a household-based seroepidemiological survey. Lancet 2001; 358:261-4.
4. Sejvar JJ. The long-term outcomes of human West Nile virus infection. Clin Infect Dis 2007; 44:1617-24.
5. Granwehr BP, Lillibridge KM, Higgs S, et al. West Nile virus: where are we now? Lancet Infect Dis 2004; 4:547-56.
6. Ben-Nathan D, Huitinga I, Lustig S, van Rooijen N, Kobiler D. West Nile virus neuroinvasion and encephalitis induced by macrophage depletion in mice. Arch Virol 1996; 141:459-69.
7. Diamond MS, Shrestha B, Mehlhop E, Sitati E, Engle M. Innate and adaptive immune responses determine protection against disseminated infection by West Nile encephalitis virus. Viral Immunol 2003; 16:259-78.
8. Diamond MS, Shrestha B, Marri A, Mahan D, Engle M. B cells and antibody play critical roles in the immediate defense of disseminated infection by West Nile encephalitis virus. J Virol 2003; 77:2578-86.
9. Oliphant T, Diamond MS. The molecular basis of antibody-mediated neutralization of West Nile virus. Expert Opin Biol Ther 2007; 7:885-92.
10. Halevy M, Akov Y, Ben-Nathan D, Kobiler D, Lachmi B, Lustig S. Loss of active neuroinvasiveness in attenuated strains of West Nile virus: pathogenicity in immunocompetent and SCID mice. Arch Virol 1994; 137:355-70.
11. Diamond MS, Sitati EM, Friend LD, Higgs S, Shrestha B, Engle M. A critical role for induced IgM in the protection against West Nile virus infection. J Exp Med 2003; 198:1853-62.
12. Engle MJ, Diamond MS. Antibody prophylaxis and therapy against West Nile virus infection in wild-type and immunodeficient mice. J Virol 2003; 77:12941-9.
13. Ratterree MS, Gutierrez RA, Travassos da Rosa AP, et al. Experimental infection of rhesus macaques with West Nile virus: level and duration of viremia and kinetics of the antibody response after infection. J Infect Dis 2004; 189:669-76.
14. Tilley PA, Fox JD, Jayaraman GC, Preiksaitis JK. Nucleic acid testing for West Nile virus RNA in plasma enhances rapid diagnosis of acute infection in symptomatic patients. J Infect Dis 2006; 193:1361-4.
15. + T cells responding to lethal West Nile virus infection. Eur J Immunol 2007; 37:1855-63.
16. Purtha WE, Myers N, Mitaksov V, et al. Antigen-specific cytotoxic T lymphocytes protect against lethal West Nile virus encephalitis. Eur J Immunol 2007; 37:1845-54.
17. + T cells mediate recovery and immunopathology in West Nile virus encephalitis. J Virol 2003; 77:13323-34.
18. + T cells in control of West Nile virus infection. J Virol 2004; 78:8312-21.
19. Shrestha B, Wang T, Samuel MA, et al. Gamma interferon plays a crucial early antiviral role in protection against West Nile virus infection. J Virol 2006; 80:5338-48.
20. + T cells require perforin to clear West Nile virus from infected neurons. J Virol 2006; 80:119-29.
21. Cheng Y, King NJ, Kesson AM. Major histocompatibility complex class I (MHC-I) induction by West Nile virus: involvement of 2 signaling pathways in MHC-I up-regulation. J Infect Dis 2004; 189:658-68.
22. Lobigs M, Arthur CE, Mullbacher A, Blanden RV. The flavivirus non-structural protein NS3 is a dominant source of cytotoxic T cell peptide determinants. Virology 1994; 202:195-201.
23. + cytotoxic T lymphocytes of dengue virus nonstructural proteins NS3 and NS1.2a. J Clin Invest 1996; 98:1684-91.
24. De Groot AS, Saint-Aubin C, Bosma A, Sbai H, Rayner J, Martin W. Rapid determination of HLA B*07 ligands from the West Nile virus NY99 genome. Emerg Infect Dis 2001; 7:706-13.
25. Schmittel A, Keilholz U, Bauer S, et al. Application of the IFN-gamma ELISPOT assay to quantify T cell responses against proteins. J Immunol Methods 2001; 247:17-24.
26. Martin DA, Noga A, Kosoy O, Johnson AJ, Petersen LR, Lanciotti RS. Evaluation of a diagnostic algorithm using immunoglobulin M enzyme-linked immunosorbent assay to differentiate human West Nile virus and St. Louis encephalitis virus infections during the 2002 West Nile virus epidemic in the United States. Clin Diagn Lab Immunol 2004; 11:1130-3.
27. + T cells from a memory to memory/effector phenotype. J Immunol 2002; 168:5538-50.
28. National Center for Biotechnology Information. Basic Local Alignment Search Tool [database online]. Available at: http://www.ncbi.nlm.nih.gov/blast/ Blast.cgi. Accessed 26 February 2008.
29. Bunce M, O'Neill CM, Barnardo MC, et al. Phototyping: comprehensive DNA typing for HLA-A, B, C, DRB1, DRB3, DRB4, DRB5 & DQB1 by PCR with 144 primer mixes utilizing sequence-specific primers (PCR-SSP). Tissue Antigens 1995; 46:355-67.
30. Institute für Transfusionsmedizin Web site. Available at: http://www.histocheck.org. Accessed 3 July 2007.
31. Rammensee H-G, Bachmann J, Emmerich NN, Bachor OA, Stevanovic S. SYFPEITHI: database for MHC ligands and peptide motifs. Immunogenetics 1999; 50:213-9.
32. + T cells vary in differentiation phenotype in different persistent virus infections. Nat Med 2002; 8:379-85.
33. Addo MM, Yu XG, Rathod A, et al. Comprehensive epitope analysis of human immunodeficiency virus type 1 (HIV-1)-specific T-cell responses directed against the entire expressed HIV-1 genome demonstrate broadly directed responses, but no correlation to viral load. J Virol 2003; 77:2081-92.
34. + responses in HIV type 1-infected patients: comparison with anti-Epstein-Barr virus responses and changes during antiretroviral therapy. J Virol 1999; 73:7108-16.
35. Sacre K, Carcelain G, Cassoux N, et al. Repertoire, diversity, and differentiation of specific CD8 T cells are associated with immune protection against human cytomegalovirus disease. J Exp Med 2005; 201:1999-2010.
36. +-T-cell responses against hepatitis C virus reveals multiple unpredicted specificities. J Virol 2002; 76:6104-13.
37. Oliphant T, Nybakken GE, Engle M, et al. Antibody recognition and neutralization determinants on domains I and II of West Nile virus envelope protein. J Virol 2006; 80:12149-59.
38. Sanchez MD, Pierson TC, McAllister D, et al. Characterization of neutralizing antibodies to West Nile virus. Virology 2005; 336:70-82.
39. Monath TP, Liu J, Kanesa-Thasan N, et al. A live, attenuated recombinant West Nile virus vaccine. Proc Natl Acad Sci U S A 2006; 103:6694-9.
40. Kutubuddin M, Kolaskar AS, Galande S, Gore MM, Ghosh SN, Banerjee K. Recognition of helper T cell epitopes in envelope (E) glycoprotein of Japanese encephalitis, West Nile and Dengue viruses. Mol Immunol 1991; 28:149-54.
41. + T cells display quantitative and qualitative differences in their response to variant epitopes of heterologous viral serotypes. J Immunol 2006; 176:2817-24.
42. + cytotoxic T lymphocyte clones. Virology 1997; 234:383- 6.
43. Imrie A, Meeks J, Gurary A, et al. Differential functional avidity of dengue virus - specific T-cell clones for variant peptides representing heterologous and previously encountered serotypes. J Virol 2007; 81:10081-91.
44. Simmons CP, Dong T, Chau NV, et al. Early T-cell responses to dengue virus epitopes in Vietnamese adults with secondary dengue virus infections. J Virol 2005; 79:5665-75.
45. Zivna I, Green S, Vaughn DW, et al. T cell responses to an HLA-B*07-restricted epitope on the dengue NS3 protein correlate with disease severity. J Immunol 2002; 168:5959-65.
46. Champagne P, Ogg GS, King AS, et al. Skewed maturation of memory HIV-specific CD8 T lymphocytes. Nature 2001; 410:106-11.
47. + T-cell responses: relationship to viral load in untreated HIV infection. J Virol 2001; 75:11983-91.
48. Draenert R, Altfeld M, Brander C, et al. Comparison of overlapping peptide sets for detection of antiviral CD8 and CD4 T cell responses. J Immunol Methods 2003; 275:19-29.
49. Herring BL, Bernardin F, Caglioti S, et al. Phylogenetic analysis of WNV in North American blood donors during the 2003-2004 epidemic seasons. Virology 2007; 363:220-8.
50. Bull M, Lee D, Stucky J, et al. Defining blood processing parameters for optimal detection of cryopreserved antigen-specific responses for HIV vaccine trials. J Immunol Methods 2007; 322:57-69.
51. Arroyo J, Miller C, Catalan J, et al. ChimeriVax-West Nile virus live-attenuated vaccine: preclinical evaluation of safety, immunogenicity, and efficacy. J Virol 2004; 78:12497-507.